Clinical correlation to differences in ranibizumab and aflibercept vascular endothelial growth factor suppression times
Author:
Publisher
BMJ
Subject
Cellular and Molecular Neuroscience,Sensory Systems,Ophthalmology
Reference12 articles.
1. Ranibizumab and bevacizumab for neovascular age-related macular degeneration;CATT Research Group;N Engl J Med,2011
2. Intravitreal aflibercept (VEGF-A trap-eye) in wet age-related macular degeneration;Heier;Ophthalmology,2012
3. Long-term stability of vascular endothelial growth factor suppression time under ranibizumab treatment in age-related macular degeneration;Muether;Am J Ophthalmol,2013
4. Vascular endothelial growth factor in patients with exudative age-related macular degeneration treated with ranibizumab;Muether;Ophthalmology,2012
5. Suppression of intraocular vascular endothelial growth factor during aflibercept treatment of age-related macular degeneration;Fauser;Am J Ophthalmol,2014
Cited by 50 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. MACULAR CHORIORETINAL ATROPHY AND VISUAL OUTCOMES IN RANIBIZUMAB- OR AFLIBERCEPT-TREATED MYOPIC CHOROIDAL NEOVASCULARIZATION;Retina;2024-01
2. Two-Year Real-World Results for Aflibercept Using the Treat-and-Extend Regimen in Neovascular Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy;Ophthalmology and Therapy;2023-11-23
3. Efficacy of Injection Interval Shortening in Neovascular Age-related Macular Degeneration with Limited Response to Bimonthly Aflibercept;Journal of the Korean Ophthalmological Society;2023-08-15
4. Towards a population pharmacokinetic/pharmacodynamic model of anti-VEGF therapy in patients with age-related macular degeneration;European Journal of Pharmaceutics and Biopharmaceutics;2023-07
5. Aflibercept for long-term treatment of diabetic macular edema and proliferative diabetic retinopathy: a meta-analysis;Frontiers in Endocrinology;2023-05-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3